MYCN and neuroblastoma: Based on the transcriptional repression mediated by MYCN and the polycomb repressive complex 2 repressive complex, targeting EZH2 (the catalytic subunit of polycomb repressive complex 2), which is overexpressed in neuroblastoma cells, is another approach that might be used to inhibit the functions of MYCN.109